FDA proposes guidance for biosimilar product labels
In proposed draft guidance issued on March 29, FDA is filling out more of the details about how biosimilars will be regulated; in this case, how product labels and medication […]
In proposed draft guidance issued on March 29, FDA is filling out more of the details about how biosimilars will be regulated; in this case, how product labels and medication […]